https://scholars.lib.ntu.edu.tw/handle/123456789/582419
標題: | Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results | 作者: | Maurer, Marcus Giménez-Arnau, Ana Ensina, Luis Felipe CHIA-YU CHU Jaumont, Xavier Tassinari, Paolo |
關鍵字: | AMAC, Asia-Pacific and the Middle East; AWARE, A Worldwide Antihistamine-Refractory Chronic Urticaria patient Evaluation; Angioedema; CIndU, chronic inducible urticaria; CSU, chronic spontaneous urticaria; CU, chronic urticaria; DLQI, dermatology life quality index; Dermatology; LaCAN, Central and Latin America; PRO, patient-reported outcome; QoL, quality of life; Quality-of-life; SD, standard deviation; UAS7, 7-day urticaria activity score; Urticaria | 公開日期: | 九月-2020 | 卷: | 13 | 期: | 9 | 來源出版物: | The World Allergy Organization journal | 摘要: | A Worldwide Antihistamine-Refractory Chronic Urticaria (CU) patient Evaluation (AWARE) is a non-interventional, multicenter study including patients from Europe, Central and Latin America, Asia-Pacific, and the Middle East. AWARE describes real-world evidence for CU, including clinical characteristics, treatment patterns and the impact on quality of life. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/582419 | ISSN: | 1939-4551 | DOI: | 10.1016/j.waojou.2020.100460 | SDG/關鍵字: | cyclosporine; histamine H1 receptor antagonist; montelukast; omalizumab; 7 day urticaria activity score; adult; angioneurotic edema; Article; chronic inducible urticaria; chronic urticaria; Dermatology Life Quality Index; drug use; female; human; major clinical study; male; patient-reported outcome; priority journal; quality of life; skin disease assessment |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。